Neoadjuvant Radiation with Concurrent 5-FU Resulting in Complete Pathologic Response in Stage IIIB Squamous Cell Carcinoma of the Urethra
Squamous cell carcinoma (SCC) of the urethra is a rare malignancy, comprising less than 1% of all malignancies. The annual age-adjusted incidence of urethral SCC is 4.3 per million in men and 1.5 per million in women. Due to the rarity of the disease, there are a limited number of prospective random...
Saved in:
Main Authors: | Krishna H. Suthar, Meghana Kesireddy, Mark Sides, Amit Correa, Aijan Ukudeyva, Rohit Venkatesan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Case Reports in Oncological Medicine |
Online Access: | http://dx.doi.org/10.1155/2020/7948538 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Locally Advanced and Unresectable Cutaneous Squamous Cell Carcinoma: Outcomes of Concurrent Cetuximab and Radiotherapy
by: Robert M. Samstein, et al.
Published: (2014-01-01) -
Neoadjuvant chemoimmunotherapy for locally advanced squamous cell carcinoma of the head and neck: Systematic review and meta-analysis
by: Xiayi Zhu, et al.
Published: (2025-02-01) -
An Unusual Presentation of Limited Granulomatosis with Polyangiitis Involving Vagina and Urethra
by: Sandra Soro Marín, et al.
Published: (2017-01-01) -
Assessment of Pathological Response of Breast Carcinoma in Modified Radical Mastectomy Specimens after Neoadjuvant Chemotherapy
by: Dhanya Vasudevan, et al.
Published: (2015-01-01) -
Pathologic Complete Response to Neoadjuvant Nivolumab/Ipilimumab in a Patient with Metastatic Renal Cell Carcinoma
by: Taylor C. Peak, et al.
Published: (2020-01-01)